www.cbsnews.com

www.cbsnews.com
Share

www.cbsnews.com

 •  October 12

SILVER SPRING, Md. — A panel of U.S. health advisers has endorsed an experimental approach to treating inherited blindness, setting the stage for the likely approval of an innovative new genetic medicine. A panel of experts to the Food and Drug Administration voted unanimously in favor of Spark Therapeutics' injectable therapy, which aims to...

www.cbsnews.com

 •  July 27

LONDON - Shares in Anglo-Swedish drugmaker AstraZeneca (AZN) plunged 15 percent on Thursday morning in premarket trading on Wall Street after a new lung cancer drug trial did not prove as successful as the company had hoped. The markets had closely watched the study, known as Mystic, because the company had hoped the drug Imfinzi, would be more...

www.cbsnews.com

 •  July 7

The U.S. Food and Drug Administration has approved the first drug in nearly 20 years for sickle cell, an inherited disease in which abnormally shaped red blood cells can't properly carry oxygen throughout the body, which can cause severe pain and organ damage. About 100,000 people in the U.S. have the disorder and about 275,000 babies are born with...

www.cbsnews.com

 •  June 28

The Food and Drug Administration said it's taking steps to boost the number of generic prescription drugs on the market in an effort to make medicines more affordable and to prevent price gouging. Copycat pills generally have been much cheaper than original brand-name drugs. But recent high-profile cases have shown how lack of competition and...

www.cbsnews.com

 •  June 9

TRENTON, N.J. -- U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drugs's risks...

www.cbsnews.com

 •  May 31

A drug called Xeloda can extend the lives of some women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds. Oncologists said the results are "practice-changing." "This drug is already approved, and we've been using it for a long time in cancer treatment," said Dr. Stephen Malamud, an oncologist at Mount Sinai in...

www.cbsnews.com

 •  May 31

COLUMBUS, Ohio - Ohio's Attorney General sued five drugmakers on Wednesday for their alleged role in the state's opiate epidemic, accusing the companies of intentionally misleading patients about the dangers of painkillers and promoting benefits of the drugs not backed by science. Attorney General Mike DeWine said the companies created a deadly...

www.cbsnews.com

 •  May 9

Almost one-third of drugs approved by the U.S. Food and Drug Administration were flagged later for safety issues, new research reveals. But it doesn't necessarily mean drugs are approved too soon, says the study author. Researchers from Brigham and Women's Hospital in Boston, the Mayo Clinic and Yale School of Medicine analyzed data on 222 new...

www.cbsnews.com

 •  May 9

For the first time in 22 years, the FDA has approved a drug for ALS, giving hope to some of those suffering from the illness. ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease, is a rare disease, affecting 12,000 to 15,000 Americans, according to the U.S. Food and Drug Administration. It attacks and kills the nerve cells that...

www.cbsnews.com

 •  May 5

The Trump administration is looking to slash the White House Office of National Drug Control Policy (ONDCP) budget by nearly 95 percent, according to a memo obtained by CBS News. The Office of Management and Budget (OMB) has proposed major ONDCP budget cuts for fiscal year 2018 that would cut 33 employees, nearly half the office staff, along with...